[The stream is slated to start at 10 a.m. ET. Please refresh the page if you do not see a player above at that time.]
The Food and Drug Administration and Centers for Disease Control and Prevention are holding a joint press briefing Tuesday after U.S. health officials asked states to temporarily halt using Johnson & Johnson's Covid-19 vaccine.
The recommendation from U.S. health officials came after six women, ages 18 to 48, developed a rare blood-clotting disorder after getting the vaccine. J&J said in a statement that "no clear causal relationship" has been identified between the blood clots and the vaccine.
Get New England news, weather forecasts and entertainment stories to your inbox. Sign up for NECN newsletters.
"Right now, these adverse events appear to be extremely rare," the FDA said in a joint statement with the CDC. "COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously."
